capsaicin has been researched along with cannabidiol in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Bisogno, T; Brandi, I; Davis, JB; De Petrocellis, L; Di Marzo, V; Hanus, L; Mechoulam, R; Moriello, AS; Ponde, DE; Tchilibon, S | 1 |
| Balali-Mood, K; Bond, SM; McQueen, DS; Smart, D; Smith, PJ | 1 |
| Colleoni, M; Costa, B; Franke, C; Giagnoni, G; Trovato, AE | 1 |
| Breuer, A; Fride, E; Hanus, L; Ponde, D | 1 |
| Maor, Y; Mechoulam, R; Pertwee, RG; Stevenson, LA; Thomas, A | 1 |
| Long, LE; Malone, DT; Taylor, DA | 1 |
| Colleoni, M; Comelli, F; Costa, B; Giagnoni, G; Trovato, AE | 1 |
| Battistin, L; Carbonare, MD; D'Arrigo, A; Facchinetti, F; Giudice, ED; Guiotto, A; Leon, A; Passarotto, M; Rinaldi, L | 1 |
| d'amico, A; de Filippis, D; de Man, JG; de Winter, BY; Esposito, G; Herman, AG; Iuvone, T; Pelckmans, PA; Steardo, L | 1 |
| Bitencourt, RM; Pamplona, FA; Takahashi, RN | 1 |
| Aguiar, DC; Campos, AC; Guimarães, FS; Lisboa, SF; Moreira, FA; Resstel, LB; Terzian, AL | 1 |
| da-Silva, CA; Del-Bel, E; Dos-Santos-Pereira, M; Guimarães, FS | 1 |
| Ambrus, L; Bíró, T; Kelemen, B; Szabó, T; Tóth, BI | 1 |
| Aboud, M; Comai, S; De Gregorio, D; Enns, J; Gobbi, G; Lopez-Canul, M; Maione, S; McLaughlin, RJ; Ochoa-Sanchez, R; Posa, L | 1 |
| Bortolanza, M; Crivelaro do Nascimento, G; Del Bel, EA; Ferrari, DP; Ferreira-Junior, NC; Guimaraes, FS | 1 |
1 review(s) available for capsaicin and cannabidiol
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
16 other study(ies) available for capsaicin and cannabidiol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
Topics: Amidohydrolases; Arachidonic Acids; Binding, Competitive; Biological Transport; Calcium; Cannabidiol; Capsaicin; Cell Line; Cell Membrane; Cytosol; Dose-Response Relationship, Drug; Endocannabinoids; Gene Expression; Humans; Hydrolysis; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug | 2001 |
Cannabidiol lacks the vanilloid VR1-mediated vasorespiratory effects of capsaicin and anandamide in anaesthetised rats.
Topics: Anesthesia; Animals; Arachidonic Acids; Blood Pressure; Cannabidiol; Capsaicin; Dose-Response Relationship, Drug; Endocannabinoids; Hyperventilation; Hypotension; Male; Polyunsaturated Alkamides; Pulmonary Ventilation; Rats; Rats, Wistar; Receptors, Drug | 2004 |
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Topics: Administration, Oral; Animals; Camphanes; Cannabidiol; Capsaicin; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hyperalgesia; Inflammation; Italy; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Drug; Rimonabant; Time Factors | 2004 |
Peripheral, but not central effects of cannabidiol derivatives: mediation by CB(1) and unidentified receptors.
Topics: Animals; Binding, Competitive; Body Temperature; Camphanes; Cannabidiol; Capsaicin; Drug Interactions; Ear, External; Gastrointestinal Motility; Inflammation; Mice; Mice, Inbred ICR; Mice, Inbred Strains; Motor Activity; Pain Measurement; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant | 2005 |
Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
Topics: Adenosine Triphosphate; Adrenergic alpha-2 Receptor Antagonists; Animals; Benzoxazines; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Capsaicin; In Vitro Techniques; Isometric Contraction; Male; Mice; Morpholines; Naloxone; Naphthalenes; Phenylephrine; Piperidines; Pyrazoles; Rimonabant; Ruthenium Red; TRPV Cation Channels; Vas Deferens; Yohimbine | 2005 |
Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice.
Topics: Analysis of Variance; Animals; Behavior, Animal; Cannabidiol; Capsaicin; Clozapine; Conditioning, Classical; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Inhibition, Psychological; Male; Mice; Reflex, Startle; Serotonin Antagonists | 2006 |
The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.
Topics: Administration, Oral; Animals; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabis; Capsaicin; Chronic Disease; Dinoprostone; Freund's Adjuvant; Hyperalgesia; Inflammation; Lipid Peroxides; Male; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Pain; Pain Measurement; Rats; Rats, Wistar; Sciatic Neuropathy; Tumor Necrosis Factor-alpha | 2007 |
Cannabidiol, unlike synthetic cannabinoids, triggers activation of RBL-2H3 mast cells.
Topics: Animals; Benzoxazines; beta-N-Acetylhexosaminidases; Calcium; Cannabidiol; Cannabinoids; Capsaicin; Cell Degranulation; Cell Line; Cyclohexanols; Dronabinol; Intracellular Fluid; Mast Cells; Morpholines; Naphthalenes; Rats; TRPV Cation Channels | 2007 |
Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.
Topics: Amidohydrolases; Animals; Cannabidiol; Capsaicin; Gastric Emptying; Gastrointestinal Motility; Intestine, Small; Lipopolysaccharides; Male; Mice; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sensory System Agents; Sepsis | 2008 |
Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Arachidonic Acids; Behavior, Animal; Cannabidiol; Capsaicin; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Extinction, Psychological; Fear; Freezing Reaction, Cataleptic; Injections, Intraventricular; Male; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant; TRPV Cation Channels | 2008 |
Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
Topics: Animals; Anti-Anxiety Agents; Cannabidiol; Cannabinoids; Capsaicin; Microinjections; Periaqueductal Gray; Rats; Receptor, Cannabinoid, CB1; Stress, Physiological; Synaptic Transmission; TRPV Cation Channels | 2009 |
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action.
Topics: Animals; Anti-Dyskinesia Agents; Arachidonic Acids; Brain; Cannabidiol; Capsaicin; Cyclooxygenase 2; Dyskinesia, Drug-Induced; Endocannabinoids; Extracellular Signal-Regulated MAP Kinases; Histones; Levodopa; Male; Mice, Inbred C57BL; NF-kappa B; Oxidopamine; Parkinsonian Disorders; Polyunsaturated Alkamides; PPAR gamma; Receptor, Cannabinoid, CB1; TRPV Cation Channels; Tyrosine 3-Monooxygenase | 2016 |
Human podocytes express functional thermosensitive TRPV channels.
Topics: Calcium; Calcium Signaling; Cannabidiol; Capsaicin; Cell Line; Diterpenes; Glomerular Filtration Barrier; Humans; Patch-Clamp Techniques; Podocytes; RNA, Messenger; TRPV Cation Channels | 2017 |
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Topics: Action Potentials; Animals; Anxiety; Cannabidiol; Capsaicin; Disease Models, Animal; Exploratory Behavior; Feeding Behavior; Ganglia, Spinal; Hyperalgesia; Lysergic Acid Diethylamide; Male; Maze Learning; Neuralgia; Piperazines; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Swimming | 2019 |
Cannabidiol increases the nociceptive threshold in a preclinical model of Parkinson's disease.
Topics: Amidohydrolases; Analgesics; Animals; Benzamides; Brain; Cannabidiol; Capsaicin; Carbamates; Celecoxib; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Morphine; Nociception; Oxidopamine; Pain; Parkinson Disease; Piperidines; Pyrazoles; Thienamycins | 2020 |